DexCom, Inc.DXCMNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+27.2%
5Y CAGR+25.3%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+27.2%/yr
Annual compound
5Y CAGR
+25.3%/yr
Consistent
Percentile
P100
Near historical high
vs 5Y Ago
3.1x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.16B | +23.0% |
| 2024 | $945.70M | +3.2% |
| 2023 | $916.70M | +62.2% |
| 2022 | $565.30M | +49.7% |
| 2021 | $377.50M | +0.2% |
| 2020 | $376.80M | +76.7% |
| 2019 | $213.20M | +385.4% |
| 2018 | $-74.70M | -279.2% |
| 2017 | $-19.70M | +60.0% |
| 2016 | $-49.20M | - |